Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2017-06-22
2018-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Influence of the "Hypotension Probability Index" on Intraoperative and Postoperative Hypotension in ENT- and OM-Surgery
NCT04151264
Hypotension Prediction Index Based Perioperative Protocolized Hemodynamic Management in Geriatric Orthopedic Surgery
NCT05274412
Hypotension Prediction Index and Intraoperative Hypotension Incidence
NCT06909786
HPI Index With GDHT in Predicting Hypotension In General Anesthesia Patients
NCT04803903
The "Hypotension Prediction Index" in Patients Undergoing Lung Surgery
NCT04149314
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Subcenter University hospital of Giessen, Department of Anesthesiology, Operative Intensive Care and Pain Therapy (Study team: Dres. med. Christian Koch, Emmanuel Schneck, Thomas Zajonz, Dagmar Schulte, Fabian Edinger, Sophie Ruhrmann) 3.3 Study Population The study population is therefore divided into three groups.
1. Intervention group (optimization based on HPI) n=25
2. Control group (optimization based on standard monitoring without HPI) n=25
Inclusion Criteria
* Patients undergoing hip-replacement
* General anesthesia
* Age ≥ 18 years
Exclusion criteria
Predefined exclusion criteria are:
* Participation in another (interventional) study
* Pregnancy and nursing mothers
* Surgery without controlled ventilation
* American Society of Anesthesiologists (ASA) score \> III
* Contraindication for invasive blood pressure monitoring
* Renal insufficiency (Kidney Disease Improving Global Outcomes (KDIGO) score Stadium ≥ 2)
* Coagulation disorder
Dropout Criteria None
Patient flow Patients are recruited before surgery after checking inclusion and exclusion criteria. Informed consent is obtained at this time. During this process also basic patients characteristics are obtained:
* Age, sex, height, weight, ASA score
* Pre-existing conditions (hypertension, state after myocardial infarction, coronary heart disease, peripheral arterial disease, renal failure, chronic obstructive pulmonary disease,diabetes)
* Previous surgeries
* Current medication
* Laboratory results
Endpoints
Primary endpoint:
• Frequency (n)/h and Duration (t \[min\]/% of total anesthesia time) of intraoperative hypotension
Secondary endpoints:
* Suspected reason for hypotension
* Quantity of intravenous volume (crystalloids, colloids, blood products and salvage blood)
* Type and dosage of vasopressors (epinephrine, norepinephrine, dobutamine)
* Cardiac output, cardiac index (CO, CI)
* Stroke volume/ stroke volume index (SV/ SVI)
* Stroke volume variation (SVV)
* Systemic vascular resistance (SVRI)
* Heart rate (HR)
* Blood pressure (BP)
* Duration of surgery, duration of anesthesia
* Blood loss
* Transfusion rate
* Net fluid intake
* Additional outcome parameter
* hospital length of stay
* intensive care length of stay
* duration of mechanical ventilation
* hemoglobin level at the end of surgery
Data Processing Data collection is carried out consistently on pre-defined time-points in our electronic patient data management system (NarkoData, IMESO Company, Giessen, Germany) into a separated study database(Microsoft Excel). Patient data is transferred to the database as pseudonyms based on a random key method. The chart with the patient data and decrypting keys is kept in the study center for at least 15 years after the end of the study (publication). Data anonymization is intentionally not performed to give patients the option for data insight or deletion of their data in the future.
Data management and evaluation is performed by the study team.
Patient number and Biometrics The aim of the study is to show the benefit of early and automated monitoring of intraoperative hypotension index in order to support automatically registration of the approach of critical situations given as probability of occurrence of hypotension.
Benefit - Risk assessment Potential benefit Based on a continuous monitoring by additional monitoring system (HPI) an early detection of potential life threatening events is possible. This can result in an optimization of the patients' therapy and a better outcome.
Potential Risks The presented study is an interventional study. The potential risks are marginal. The usage of an arterial catheter is based on preexisting diseases, to monitor the blood pressure continuously. The risk of arterial injuries, infection, fistula etc. is minimal. The time points of blood samples for the study are in line with routine sampling. Based on this, there is no additional risk for the patient.
Benefit/ Risk analysis The benefit for the patients is additional monitoring, based on an additional monitoring device and the supervising study doctor, who can support the treating anesthesiologist with information in potentially critical situations. Thereby, it is possible to treat early goal-directed and possibly improve the patients outcome. Considering the potential benefits of the generated information for the patient in comparison to the expected risks, the beneficial effect is overbalanced.
The expected gain in knowledge from this study could be used for optimizing perioperative care.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention arm
HPI monitoring to predict hypotension
Hypotension probability index (HPI)
The intervention group is managed with the HPI parameter to detect and possibly prevent hypotension during anaesthesia.
Control arm
blinded HPI monitoring
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hypotension probability index (HPI)
The intervention group is managed with the HPI parameter to detect and possibly prevent hypotension during anaesthesia.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* General anesthesia
* Age ≥ 18 years
Exclusion Criteria
* Pregnancy and nursing mothers
* Surgery without controlled ventilation
* ASA \> III
* Contraindication for invasive blood pressure monitoring
* Renal insufficiency KDIGO Stadium ≥ 2
* Coagulation disorder
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Giessen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Christian Koch
MD, Principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Michael Sander
Giessen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Schneck E, Schulte D, Habig L, Ruhrmann S, Edinger F, Markmann M, Habicher M, Rickert M, Koch C, Sander M. Hypotension Prediction Index based protocolized haemodynamic management reduces the incidence and duration of intraoperative hypotension in primary total hip arthroplasty: a single centre feasibility randomised blinded prospective interventional trial. J Clin Monit Comput. 2020 Dec;34(6):1149-1158. doi: 10.1007/s10877-019-00433-6. Epub 2019 Nov 29.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09/17
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.